Please login to order a test.
This assay uses LC/MS-MS to quantify the free acid, glycine-conjugate and taurine-conjugate forms of cholic acid, chenodeoxycholic acid, deoxycholic acid, and ursodeoxycholic acid. Bile acids may be measured to investigate obstructive cholestasis in pregnancy.1 In addition, bile acids are required for cholesterol absorption, fat-soluble vitamin absorption, and to provide resistance to overgrowth of intestinal bacteria.1 Bile acid levels may be reduced or elevated due to various genetic defects.
High-pressure liquid chromatography/tandem mass spectrometry (HPLC/MS-MS)
Bile acids are formed in the liver from cholesterol, stored and concentrated in the gallbladder, and excreted into the intestines in response to food. The liver synthesizes cholesterol into two primary bile acids, cholic acid and chenodeoxycholic acid. The primary bile acids are converted by intestinal bacteria to the secondary bile acids, deoxycholic acid and lithocholic acid. A fraction of chenodeoxycholic acid is also transformed into the tertiary bile acid, ursodeoxycholic acid.
Serum (preferred) or plasma, frozen
0.3 mL (Note: This volume does not allow for repeat testing.)
Red-top tube, gel-barrier tube, lavender-top (EDTA) tube, or green-top (sodium heparin) tube
Patient should be fasting.
Serum/plasma must be separated from cells within two hours of venipuncture. Transfer serum/plasma to a plastic transport tube before freezing.
Refrigerate or freeze.
Causes for Rejection
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|503640||Bile Acids, Fractionated LCMS||503642||Ursodeoxycholic Acids||umol/L||55159-8|
|503640||Bile Acids, Fractionated LCMS||503643||Cholic Acids||umol/L||30518-5|
|503640||Bile Acids, Fractionated LCMS||503644||Chenodeoxycholic Acids||umol/L||30519-3|
|503640||Bile Acids, Fractionated LCMS||503645||Deoxycholic Acids||umol/L||30520-1|
|503640||Bile Acids, Fractionated LCMS||503641||Total Bile Acids||umol/L||14628-2|